advertisement
Reply
 
Thread Tools Display Modes
Old 03-23-2017, 11:50 AM #1
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Post Louisville company US Worldwide Meds will market new Parkinson's drug - The Courier-J


The Courier-Journal


Louisville company US Worldwide Meds will market new Parkinson's drug
The Courier-Journal
A Louisville company has been chosen to market a new drug just approved by the Food and Drug Administration to treat Parkinson's disease. US Worldwide Meds, a specialty pharmaceutical company, will market Xadago, the first drug given clearance in a ...
FDA OKs Parkinson's Add-On DrugFremont Tribune
FDA approves drug to treat Parkinson's diseaseFDA.gov
New Parkinson's Drug Xadago ApprovedU.S. News & World Report
MedCity News -UPI.com -CBS DFW
all 54 news articles »


More...
NewsBot is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
drug, parkinson's, market, company, news


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On


Similar Threads
Thread Thread Starter Forum Replies Last Post
Seniors strive to KO Parkinson's - The Record-Courier NewsBot Parkinson's News 0 06-27-2016 01:50 PM


All times are GMT -5. The time now is 12:18 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.